HOLMAN ANDREW J has a total of 12 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2001. It filed its patents most often in Australia, Brazil and Canada. Its main competitors in its focus markets pharmaceuticals and biotechnology are OHLENSCHLAEGER GERHARD, CERENIS THERAPEUTICS S A and SHANGHAI INST OF CELL BIOLOGY.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 1 | |
#2 | Brazil | 1 | |
#3 | Canada | 1 | |
#4 | China | 1 | |
#5 | Czechia | 1 | |
#6 | EPO (European Patent Office) | 1 | |
#7 | Mexico | 1 | |
#8 | Norway | 1 | |
#9 | Poland | 1 | |
#10 | United States | 1 | |
#11 | WIPO (World Intellectual Property Organization) | 1 | |
#12 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Holman Andrew J | 12 |
Publication | Filing date | Title |
---|---|---|
US2018117148A1 | Compounds, pharmaceutical compositions and methods of treatments of immune related diseases and disorders | |
CZ2003417A3 | Use of dopamine D2/D3 agonist receptors for treating fibromyalgia |